Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano Calcium Hydroxide as Intracanal Medication in Permanent Molars
NCT06196515Phase 3Recruiting
- Sponsor
- The British University in Egypt
- Start
- Aug 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nanocalcium hydroxide in apical periodontitis (AP), sponsored by The British University in Egypt. Started Aug 2024; status: recruiting.
02
Drugs
nanocalcium hydroxide
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on NCT06196515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06196515.